X
Search
X

Patient Support Hotline

Call (844) 244-1309

ZERO360 is a free, comprehensive patient support service to help patients and their families navigate insurance and financial obstacles to cover treatment and other critical needs associated with cancer.

X

Subscribe to our E-Newsletter

Stay up-to-date on the latest news about prostate cancer. Join our distribution list to receive periodic email updates and our monthly e-newsletter.

  • Patient Support (844) 244-1309
  • Search
  • e-News Signup Enews Signup
  • Run/Walk
  • Donate

LEGISLATIVE ALERT: Bill Prioritizing Those at At-Risk for Prostate Cancer Hits House Floor

MEDIA CONTACT:
Ilana Ostrin, Media Relations
(202) 657-2249
ilana@zerocancer.org

Bipartisan legislation would waive prostate cancer screening cost-sharing for at-risk populations 

Washington, D.C. March 4, 2021 – Late last month, the Prostate-Specific Antigen Screening for High-risk Insured Men (PSA Screening for HIM) Act (H.R. 1176) was reintroduced on the House floor. ZERO – The End of Prostate Cancer, the leading national nonprofit in the fight against this disease, is proud to be an ongoing supporter of this bill and its proposal to eliminate screening cost-sharing for high-risk individuals.

This bipartisan legislative proposal aims to waive cost-sharing requirements for men with the highest risk of prostate cancer. The high-risk populations included in the legislation are Black men and those with a family history of the disease. The bill was previously introduced in the House by Representatives Bobby L. Rush (D-Ill.) and Larry Bucshon, M.D. (R-Ind.) on November 24, 2019. 

“I am proud to have introduced the PSA Screening for HIM Act again this Congress.  I firmly believe that no one should ever need to forego a possibly lifesaving cancer screening due to cost,” said Rep. Rush.  “Early detection can quite literally be the difference between life and death and this is particularly true for those with the highest risk of developing prostate cancer.”

If the bill passes, men at an increased risk of developing prostate cancer would be able to receive prostate cancer screenings without deductibles, copayments, or coinsurances. Early detection is critical for overcoming prostate cancer: if the disease is caught early, there is a nearly 100 percent chance of survival. When the disease is caught in its advanced stages, however, the likelihood of survival drops to just 30 percent. 

“Access to and the ability to afford prostate cancer screenings shouldn’t be a barrier to receiving a simple and potentially life-saving diagnosis,” said ZERO’s VP of Government Relations & Advocacy, Alison Manson. “This effort has the power to give millions of men parity to free and easy-to-access cancer screenings, which are common among other cancers with similar impacts, like breast or ovarian.”

For the at-risk populations included in the legislation, this development could be critical to their likelihood of survival. Black men are more than twice as likely to die from prostate cancer than white men due to a lack of access to testing and care. This legislation is one of the many ways ZERO is engaged in combating the longstanding health inequities within prostate cancer. And, for men that have a family history of prostate cancer, a diagnosis is twice as likely compared to the average population.

New reporting released in early 2021 stated that prostate cancer diagnoses in 2021 are expected to reach historic highs, reaching nearly 250,000 cases; this means that an individual will be diagnosed every two minutes. Deaths are also anticipated to reach unprecedented highs, with nearly 132,000 expected to perish from the disease — that’s one person every 15 minutes. The prevalence and morbidity of prostate cancer — which is the second-most populous cancer among men —  exemplifies the urgent need for parity with other cancers for cost-free screenings. Black men are 80 percent more likely to receive a prostate cancer diagnosis than non-Hispanic white men.

Original cosponsors of H.R. 1176 include Brian Babin, D.D.S. (R-Texas), Susan Brooks (R-Ind.), André Carson (D-Ind.), Judy Chu (D-Calif.), Steve Cohen (D-Tenn.), Neal Dunn, M.D. (R-Fla.), Peter King (R-N.Y.), Gregory Meeks (D-N.Y.), Greg Murphy, M.D. (R-N.C.), Donald Payne Jr. (D-N.J.), Phil Roe, M.D. (R-Tenn.), David Scott (D-Ga.), Terri Sewell (D-Ala.), and Roger Williams (R-Texas). New co-sponsors include Brian Fitzpatrick (R-Pa.), Sanford Bishop (D-Ga.), Blunt Rochester (D-Del.), Bennie G. Thompson (D-Miss.), Anthony Gonzalez (R-Ohio), Cynthia Axne (D-Iowa), David Scott (D-Ga.), Albio Sires (D-N.J.), Jahana Hayes (D-Conn.), and Roger Williams (R-Texas).

In addition to this legislation at the national level, ZERO is also working to increase parity for prostate cancer screenings at the state level. Recent legislative wins for ZERO include the passing of a bill in Maryland that removes prostate cancer screening cost-sharing for men ages 20-75 in the state. The law went into effect in January of this year. 

To take action on behalf of H.R. 1176, contact your Congressional representatives by clicking here


About ZERO — The End of Prostate Cancer
ZERO — The End of Prostate Cancer is the leading national nonprofit with the mission to end prostate cancer. ZERO advances research, improves the lives of men and families, and inspires action. We’re building Generation ZERO, the first generation of men free from prostate cancer, through our national run/walk series, education and patient support programs, and grassroots advocacy. ZERO is a 501(c)(3) philanthropic organization recognized with four out of four stars by Charity Navigator, accredited by the Better Business Bureau, with regional chapters across the country. We dedicate 85 cents of every dollar to research and programs. For more information, visit www.zerocancer.org.